5,6-Dibromo-2,1,3-benzothiadiazole>98.0%(GC)5g

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile>98.0%(GC)(T)5g

tert-Butyl 8-(fluoromethyl)-2,6-diazaspiro[3.4]octane-2-carboxylate, 98%, 100mg

D-Valine Methyl Ester Hydrochloride>98.0%(N)5g

4-(chloromethyl)-2-methylpyridine hydrochloride, 95.0%, 250mg

(S)-2-Trifluoromethylpiperidine hydrochloride, 5g

(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(naphthalen-2-yl)butanoic acid, 97%, 250mg

Sel de potassium de l'acide gluconique, min 99 %, pour la synthèse, 500 g, emballage plastique.

N-(6-Bromopyridin-2-yl)-N-methylacetamide, 95.0%, 250mg

Ethyl 4-bromo-1H-pyrazole-3-carboxylate, 95.0%, 10g

Ethyl 2-cyano-3-phenylpropanoate, 98%, 5g

5-Bromo-2-fluoro-4-methylpyridine, 98.0%, 500g

n-Cyclobutyl-2-methoxypyridin-3-amine, 98%, 50mg